Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 18, 2010Diabetes Obesity and Metabolism

Effect of sulphonylurea treatment on glycaemic control is related to TCF7L2 genotype in patients with type 2 diabetes

View Full Paper
Ask AI
Bookmark
Share

Authors

ZSZbyněk SchronerUniversity of Veterinary Medicine in Košice
Martin Javorský
Martin JavorskýUniversity of Pavol Jozef ŠafárikLKLucia KlimčákováUniversity of Pavol Jozef Šafárik

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Schroner et al. (2010) studied this question.

synapsesocial.com/papers/6a7ff0e35eb4cdfc7531adc3https://doi.org/10.1111/j.1463-1326.2010.01324.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1TCF7L2 Polymorphisms and Progression to Diabetes in the Diabetes Prevention Program2006 · 844 citations
  2. 2Common Single Nucleotide Polymorphisms in TCF7L2 Are Reproducibly Associated With Type 2 Diabetes and Reduce the Insulin Response to Glucose in Nondiabetic Individuals2006 · 375 citations
  3. 3Ser1369Ala Variant in Sulfonylurea Receptor Gene ABCC8 Is Associated With Antidiabetic Efficacy of Gliclazide in Chinese Type 2 Diabetic Patients2008 · 155 citations
  4. 4TCF7L2 Variant rs7903146 Affects the Risk of Type 2 Diabetes by Modulating Incretin Action2009 · 165 citations